Current air pollution standards tied to higher heart risks
Long-term exposure to air pollution is tied to an increased risk of having a heart attack or dying from heart disease—with the greatest harms impacting under-resourced communities, new Kaiser Permanente research shows. The study, published February 24 in JAMA Network…
Read More
FDA Approves Once-Weekly Product for Hemophilia A
The US Food and Drug Administration (FDA) has approved efanesoctocog alfa (Altuviiio), a first-in-class, high-sustained factor VIII replacement therapy for adults and children over 12 years old with hemophilia A. The product is used once a week and is indicated…
Read More
How to overcome a midday energy slump and get energised for the afternoon
Do you ever find yourself completely knackered by midday? You got up in a rush, grabbed a quick bite to eat for breakfast (or maybe you forgot), powered through hours of productive work and then filled up on a carby…
Read More
Mystical and insightful psychedelic experience may be linked to positive mental health outcomes
A more mystical and insightful psychedelic drug experience may be linked to an enduring reduction in anxiety and depression symptoms, according to a new study. Researchers conducted a machine learning analysis of data from nearly 1,000 respondents to a survey…
Read More
New Influx of Humira Biosimilars May Not Drive Immediate Change
Gastroenterologists in 2023 will have more tools in their arsenal to treat patients with Crohn’s disease or ulcerative colitis. As many as 8-10 adalimumab biosimilars are anticipated to come on the market this year, giving mainstay drug Humira some vigorous…
Read More
Neoadjuvant Chemotherapy Underused in Breast Cancer
The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaway Neoadjuvant chemotherapy remains underused in triple negative and HER2-positive breast cancer, possibly because women are more likely to…
Read More
Real-World Survival Benefit With CDK4/6 Inhibitors in MBC
A real-world analysis shows “meaningful” overall survival benefits when a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor is added to endocrine therapy for older women with HR-positive/HER2-negative metastatic breast cancer (MBC). Three years after starting first-line treatment, overall survival rates…
Read More
Clinical trials often overlook people with disabilities, shows analysis
Source: Read Full Article
Read More
Intermittent fasting is detrimental to immune system, study says
Trendy intermittent fasting may RAISE your risk of infections, heart disease and CANCER, study suggests Scientists in New York found that skipping meals can trigger more inflammation They warned this could raise the risk of heart disease and cancer READ…
Read More